Category Archives for Newly Diagnosed

Multiple Myeloma Patients are ALL “Toxicity-Vulnerable”

Are you a “Toxicity-Vulnerable” Multiple Myeloma Patient?”  It isn’t just old people who are “vulnerable to chemotherapy toxicity.” Everyone suffers collateral damage

Continue reading

Cancer Prehabilitation-

Cancer prehabilitation is emerging as a method of better preparing patients for the often toxic and disabling effects of cancer treatment. Its place within the continuum of cancer care is rapidly being

Continue reading

Multiple Myeloma-More Chemo Is Not Better-

Two concepts have become standard practice in the treatment of multiple myeloma- low-dose maintenance therapy and metronomic therapy. If you click the links and read the info,  you will see that the terms

Continue reading

Myeloma Diagnosis: What Next?

What Does Being Diagnosed with an “Incurable but Treatable Cancer” Mean for Multiple Myeloma Patients and Survivors? When I was diagnosed in ’94, I had never heard of multiple myeloma

Continue reading

Chemotherapy-Induced Nerve Pain (CIPN) in Multiple Myeloma

“Chemotherapy-induced peripheral neuropathy (CIPN) may negatively influence multiple myeloma (MM) patients’ health-related quality of life.” While there is a long and growing list of

Continue reading

Blogging as Multiple Myeloma Cancer Therapy

A study in the February issue of the Oncologist reports that multiple myeloma patients who engaged in expressive writing just before treatment felt markedly better, mentally and physically I have been

Continue reading

Myeloma Cancer Coaching-“Is my oncologist speaking a foreign language?!”

Translate Confusing Multiple Myeloma terms and phrases A diagnosis of multiple myeloma is difficult. The last thing cancer patients and caregivers need is cancer jargon- confusing lingo- from their oncologist. 

Continue reading

Hyperbaric oxygen therapy (HBOT) for Autologous Stem Cell Transplants

“A typical course of hyperbaric oxygen treatments increases by eight-fold the number of stem cells circulating in a patient’s body” Autologus peripheral blood stem cell transplantation (ASCT)

Continue reading

Five Steps to Put Multiple Myeloma Patients in Control

Multiple Myeloma Patients and Survivors Must Learn about both Conventional and Non-Conventional Therapies in Order to Manage Their Cancers Successfully Kathy Giusti, fellow long term multiple myeloma survivor

Continue reading

Multiple Myeloma + Intravenous Vitamin C

PAA (intravenous vitamin c) selectively kills CD138+MM tumor cells derived from MM and smoldering MM (SMM) Leukemia, lymphoma and multiple myeloma all have a robust collection of FDA approved,  standard-of-care

Continue reading
1 2 3 31